Invention Grant
- Patent Title: Compositions and use of EPAS1 inhibitors
- Patent Title (中): EPAS1抑制剂的组成和用途
-
Application No.: US12384475Application Date: 2009-04-03
-
Publication No.: US08114983B2Publication Date: 2012-02-14
- Inventor: Mark E. Davis , Jeremy D. Heidel , Joanna Yi-Ching Liu
- Applicant: Mark E. Davis , Jeremy D. Heidel , Joanna Yi-Ching Liu
- Applicant Address: US CA Pasadena
- Assignee: Calando Pharmaceuticals, Inc.
- Current Assignee: Calando Pharmaceuticals, Inc.
- Current Assignee Address: US CA Pasadena
- Agency: Fanelli Haag PLLC
- Main IPC: C07H21/04
- IPC: C07H21/04 ; A61K31/70
Abstract:
The present invention relates to inhibitors of endothelial PAS domain protein 1 (EPAS1), and methods and compositions related to the EPAS1 inhibitors. In certain embodiments, the EPAS1 inhibitors include nucleic acids, such as for example siRNAs.
Public/Granted literature
- US20100010071A1 Compositions and use of EPAS1 inhibitors Public/Granted day:2010-01-14
Information query
